Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Magazzini

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|June 2, 2011
The productivity crisis in pharmaceutical R&DFabio Pammolli, Laura Magazzini, Massimo Riccaboni
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 5, 2011
The sustainability of European health care systems: beyond income and agingFabio Pammolli, Massimo Riccaboni, Laura Magazzini
Health Policy (Amsterdam, Netherlands)|August 19, 2025
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysisSimona Gamba, Laura Magazzini, Paolo Pertile
Journal of Health Economics|September 16, 2021
R&D and market size: Who benefits from orphan drug legislation?Simona Gamba, Laura Magazzini, Paolo Pertile
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Dynamic competition in pharmaceuticals. Patent expiry, generic penetration, and industry structureLaura Magazzini, Fabio Pammolli, Massimo Riccaboni
Applied Health Economics and Health Policy|July 1, 2026
The Price of National Pharmaceutical Pricing in the EU: A Proposal for "Common Procurement"Markus Frischhut, Simona Gamba, Laura Magazzini, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|June 2, 2011
The productivity crisis in pharmaceutical R&DFabio Pammolli, Laura Magazzini, Massimo Riccaboni
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 5, 2011
The sustainability of European health care systems: beyond income and agingFabio Pammolli, Massimo Riccaboni, Laura Magazzini
Health Policy (Amsterdam, Netherlands)|August 19, 2025
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysisSimona Gamba, Laura Magazzini, Paolo Pertile
Journal of Health Economics|September 16, 2021
R&D and market size: Who benefits from orphan drug legislation?Simona Gamba, Laura Magazzini, Paolo Pertile
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Dynamic competition in pharmaceuticals. Patent expiry, generic penetration, and industry structureLaura Magazzini, Fabio Pammolli, Massimo Riccaboni
Applied Health Economics and Health Policy|July 1, 2026
The Price of National Pharmaceutical Pricing in the EU: A Proposal for "Common Procurement"Markus Frischhut, Simona Gamba, Laura Magazzini, et al.
Pageof 1